Effect of OCT B-Scan Density on Sensitivity for Detection of Intraretinal Hyperreflective Foci in Eyes with Age-Related Macular Degeneration.

AMD IHRF Intraretinal hyperreflective foci OCT SD-OCT age-related macular degeneration retinal diseases

Journal

Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 24 5 2022
medline: 30 8 2022
entrez: 23 5 2022
Statut: ppublish

Résumé

To evaluate the impact of reducing the density of B-scans in an optical coherence tomography (OCT) volume on the sensitivity for detecting intraretinal hyperreflective foci (IHRF) in eyes with intermediate age-related macular degeneration (AMD). A total of 165 eyes with intermediate AMD and IHRF were evaluated in this retrospective analysis. For each case, Cirrus HD-OCT volumes were imported into the reading center 3 D-OCTOR software. The number of IHRF cases was assessed based on all 128 B-scans (spaced 47 μm apart), using a categorical scale (graded as 1-4, 5-9, 10-14, 15-19, and >20). Additionally, the B-scan densities in the volume were lowered to 64 B-scans (spaced 94 μm apart), 43 B-scans (spaced 140 μm apart), and 32 B-scans (spaced 188 μm apart). The number of eyes with any IHRF and the numerical category of IHRF in the eye were used to compare the sensitivity at each reduced B-scan density against the reference 128 B-scan volume. In the primary analysis for the qualitative presence or absence of any IHRF, the sensitivity decreased to 98.2% ( Increasing the inter-B-scan spacing from 47 to 188 microns significantly reduced the ability to accurately determine whether IHRF were present in an eye. An increase in inter-B-scan spacing to 140 microns was associated with a significant misclassification of the IHRF quantity. These findings may be relevant in the design of OCT scanning protocols for studies utilizing these biomarkers for AMD progression.

Identifiants

pubmed: 35603911
doi: 10.1080/02713683.2022.2081981
pmc: PMC10350297
mid: NIHMS1911843
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1294-1299

Subventions

Organisme : NEI NIH HHS
ID : R01 EY023164
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY030614
Pays : United States

Références

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3431-3439
pubmed: 30025092
Ophthalmology. 2019 Dec;126(12):1667-1674
pubmed: 31281056
Acta Ophthalmol. 2012 Jun;90(4):e274-80
pubmed: 22429902
Can J Ophthalmol. 2021 Oct;56(5):325-334
pubmed: 33539821
Prog Retin Eye Res. 2008 Jan;27(1):45-88
pubmed: 18036865
Ophthalmologica. 2013;229(1):32-7
pubmed: 23006969
Ophthalmology. 2013 Dec;120(12):2656-2665
pubmed: 23830761
JAMA Ophthalmol. 2020 Jul 1;138(7):740-747
pubmed: 32379287
Eye (Lond). 2017 Jan;31(1):53-61
pubmed: 27911444
Retina. 2019 Aug;39(8):1540-1550
pubmed: 29746403
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):974-8
pubmed: 15728555
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1071-8
pubmed: 19797199
Ophthalmology. 2013 May;120(5):1038-45
pubmed: 23352193
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1551-1558
pubmed: 28534244
Arch Ophthalmol. 2003 Nov;121(11):1621-4
pubmed: 14609922
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):839-48
pubmed: 17251486
Arch Ophthalmol. 2005 Nov;123(11):1570-4
pubmed: 16286620
Ophthalmology. 2006 Feb;113(2):285-93
pubmed: 16406542
Arch Ophthalmol. 2005 Nov;123(11):1484-98
pubmed: 16286610
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1839-46
pubmed: 27082298
Retina. 2015 Apr;35(4):638-47
pubmed: 25650713
Ophthalmology. 2011 Apr;118(4):687-93
pubmed: 21093923
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO211-BIO226
pubmed: 28785769
J Clin Med. 2015 Mar;4(3):424-40
pubmed: 25905023

Auteurs

Deniz Oncel (D)

Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Navid Manafi (N)

Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Muneeswar Gupta Nittala (MG)

Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Swetha Bindu Velaga (SB)

Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Dwight Stambolian (D)

Ophthalmology and Genetics, University of Pennsylvania, Philadelphia, PA, USA.

Margaret A Pericak-Vance (MA)

Hussman Institute for Human Genomics, University of Miami, Miami, FL, USA.

Jonathan L Haines (JL)

Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, USA.

Srinivas R Sadda (SR)

Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH